Screener/Healthcare/Biotechnology

KROS

Keros Therapeutics, Inc.NASDAQ
$11.01-0.23 (-2.05%)
Small CapUnder $20Healthcare
$9.12
$22.55
$10.71
$11.40
EPS (TTM)$1.56
P/E Ratio7.06
Dividend Yield—
Market Cap$421.0M
Volume326K
Prev Close$11.24
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$14.1M-$7.3M$-0.18—-51.5%
Q2 '25$18.2M-$30.7M$-0.76—-169.0%
Q1 '25$211.2M$148.5M$3.62—70.3%
Q4 '24$3.0M-$46.0M$-1.12—-1513.0%
Q3 '24$388K-$53.0M$-1.41—-13648.5%
Q2 '24$37K-$45.3M$-1.25—-122316.2%
Q1 '24$83K-$43.1M$-1.21—-51944.6%
Q4 '23$143K-$40.2M$-1.34—-28142.0%
Get Your Daily Market Recap